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Abstract
Klebsiella pneumoniae is a bacterial pathogen of worldwide importance and a significant contributor to multiple disease
presentations associated with both nosocomial and community acquired disease. ATCC 43816 is a well-studied K.
pneumoniae strain which is capable of causing an acute respiratory disease in surrogate animal models. In this study, we
performed sequencing of the ATCC 43816 genome to support future efforts characterizing genetic elements required for
disease. Furthermore, we performed comparative genetic analyses to the previously sequenced genomes from NTUH-K2044
and MGH 78578 to gain an understanding of the conservation of known virulence determinants amongst the three strains.
We found that ATCC 43816 and NTUH-K2044 both possess the known virulence determinant for yersiniabactin, as well as a
Type 4 secretion system (T4SS), CRISPR system, and an acetonin catabolism locus, all absent from MGH 78578. While both
NTUH-K2044 and MGH 78578 are clinical isolates, little is known about the disease potential of these strains in cell culture
and animal models. Thus, we also performed functional analyses in the murine macrophage cell lines RAW264.7 and J774A.1
and found that MGH 78578 (K52 serotype) was internalized at higher levels than ATCC 43816 (K2) and NTUH-K2044 (K1),
consistent with previous characterization of the antiphagocytic properties of K1 and K2 serotype capsules. We also
examined the three K. pneumoniae strains in a novel BALB/c respiratory disease model and found that ATCC 43816 and
NTUH-K2044 are highly virulent (LD50,100 CFU) while MGH 78578 is relatively avirulent.
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Introduction
Klebsiella pneumoniae ssp. pneumoniae (K. pneumoniae) is
responsible for emerging infectious disease and is a causative agent
of both nosocomial and community acquired pneumonia (CAP)
worldwide. The epidemiology of K. pneumoniae is complex,
involving ecological persistence as well as carriage in both animal
and human populations [1]. Carriage of K. pneumoniae is
frequently associated with colonization of the upper respiratory
tract or gastrointestinal (GI) tract, with the potential for GI tract
amplification of antibiotic resistant strains of K. pneumoniae
following antibiotic therapies [2]. K. pneumoniae opportunistically
infects a variety of mucosal surfaces with the primary sites of
infection including the urinary tract and the lower respiratory tract
(LRT) [3].
K. pneumoniae pneumonia is a fatal disease with mortality rates
of up to 22.7% [4,5]. The incidence of K. pneumoniae pneumonia
in the United States is more commonly associated with nosocomial
acquisition of disease rather than environmental sources [6,7], as
Klebsiella is thought to contribute to only 1% of CAP in North
America [8,9,10]. K. pneumoniae is the fifth most prevalent
nosocomial bacterial pathogen in the United States for infections
associated with UTIs, VAP and central line-associated bacteremia,
and accounts for 6% of all nosocomial bacterial disease [11]. The
emergence of K. pneumoniae as a nosocomial pathogen in the US
and Europe may be due in part to the acquisition of antibiotic
resistance markers providing a selective advantage in hospital
settings, with particular concerns growing over an increasing
prevalence of carbapenemase-expressing K. pneumoniae (KPC)
strains [12]. Well characterized outbreaks of KPC dating back to
1988 have still not led to effective clinical diagnosis or control of
these emerging pathogens in the US over 20 years later [13,14].
Recently instated surveillance programs have begun to character-
ize the increasing threat of K. pneumoniae in the US health care
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system, where it is understood that the threat of K. pneumoniae,
and in particular KPC, may be underestimated, particularly in
long-term acute care facilities [15].
Several virulence determinants are important in mediating the
virulence of K. pneumoniae in the lung, including capsular
polysaccharide, lipopolysaccharide, enterobacterial common anti-
gen, OmpA, OmpK36, the AcrAB efflux pump, the regulator
RamA, the biofilm related factor YciI, and yersiniabactin
[16,17,18,19,20,21,22,23], however, additional undescribed sys-
tems may participate in K. pneumoniae virulence. To this end,
numerous sequencing efforts have begun to characterize the
genomes of K. pneumoniae strains including the first whole
genome sequences of the clinical isolates MGH 78578 and
NTUH-K2044 [24], and the more recent release of whole genome
sequences of the strains HS11286 [25] and KCTC 2242 [26].
Comparative genetic analyses have successfully led to the
identification and characterization of a novel allantoin metabolism
locus required for GI tract disease which is present in the genome
of NTUH-K2044, but absent from MGH 78578 [27].
The ATCC 43816 strain has been the focus of several studies
characterizing the respiratory disease caused by K. pneumoniae
[16,18,28], however this strain has not been sequenced, thus
limiting investigations directed at identification of novel virulence
determinants. To address this scientific gap, we have performed
whole genome sequencing of ATCC 43816 to begin the
characterization potential genomic differences relative to the
sequenced K. pneumoniae strains.
We also decided to investigate host-pathogen interaction for the
sequenced K. pneumoniae strains NTUH-K2044 and MGH
78578, for which little is known about their ability to cause
respiratory disease or interact with professional phagocytes. We
developed a novel pulmonary-specific delivery respiratory disease
model in which to examine sequenced K. pneumoniae strains.
Finally, we have characterized the ability of K. pneumoniae to
modulate uptake and persist within multiple cultured murine
macrophage cell lines.
Materials and Methods
Bacterial strains and media
K. pneumoniae strains were cultured routinely in Lennox Broth
(LB) or LB agar plates at 37uC. K. pneumoniae was preconditioned
for cell culture and animal studies by subculturing overnight broth
cultures 1:25 into TSBDC [29] for an additional 3 hr of growth at
37uC. Briefly, TSBDC is formulated as a concentrate of a 30 g/L
trypticase soy broth mixed with 5 g/L of Chelex 100 in a 1/10th
volume, which is dialyzed from a 6–8 kDa dialysis tubing into a 1x
volume of 1% glycerol, where the media consists of the small
organic compounds which leave the dialysis tubing into the 1%
glycerol solution. TSBDC is supplemented with 50 mM mono-
sodium glutamate immediately prior to use. The bacterial cultures
were washed into PBS and their concentration was estimated using
OD600 measurements. The K. pneumoniae strains used in this
study included ATCC 43816, MGH 78578 (kindly provided by
Virginia Miller, UNC), NTUH-K2044 (kindly provided by Jin-
Town Wang, NTUCM and Valley Stewart, UC Davis), and CIP
52.145 (Collection of Institut Pasteur). Where appropriate,
antibiotics were used at the following concentrations unless
otherwise stated: carbenicillin (100 mg/ml), kanamycin (25 mg/
ml), zeocin (100 mg/ml), and gentamicin (20 mg/ml).
Sequencing of K. pneumoniae ATCC 43816
ATCC 43816 genomic DNA was isolated from ,56109
bacteria grown in LB broth overnight. The DNA was isolated in
TE buffer with 0.5% SDS extraction in the presence of proteinase
K and RNase, followed by phenol:chloroform:isoamyl alcohol
(25:24:1 v/v) purification, and alcohol precipitation. A 1.5 mg
aliquot of chromosomal DNA was processed for Illumina Next
Generation Sequencing based on the manufacturer’s instructions.
Briefly, fragmentase (NEB) was used to generate 100–300 bp
DNA fragments which were end repaired, A-tailed, adaptor
ligated, and PCR amplified using Phusion. Two lanes of 51 base
reads were run to generate 22,422,915 reads of sequencing data,
filtered to eliminate low quality reads, and assembled using Velvet
[30]. We assembled 1763 contigs, of which 1550 contigs were .
200 bp and were deposited at DDBJ/EMBL/GenBank under the
accession APWN00000000. The version described in this paper is
the first version, APWN01000000. The contigs were aligned
against the non-redundant nucleotide database using BLASTN
[31] and hits to the full genomes of the NTUH-K2044 and MGH
78578 strains were retained separately. Manual sorting was
conducted to identify contigs common to or unique from the
NTUH-K2044 and MGH 78578 genomes, and unique sequence
was aligned by BLASTN to identify homology to other bacterial
species.
The capsular polysaccharide genetic cluster was manually
sequenced to close contig gaps between five contigs, as described
elsewhere [32], and the complete sequence for the ATCC 43816
capsular polysaccharide locus have been deposited with DDBJ/
EMBL/GenBank with the accession number KJ541664.
Quantification of capsular polysaccharide production
Capsule production was quantified for K. pneumoniae from LB
overnight cultures, as described elsewhere [33]. Briefly, PBS-
washed bacteria were enumerated and subjected to hot phenol
extraction before precipitating the chloroform-treated aqueous
phase with 0.5 M sodium acetate and then 10 volumes of 95%
ethanol. Polysaccharide was pelleted at 7200 g for 5 min after an
overnight storage at 220uC. The pellet was resuspended in water,
and uronic acid was measured from capsular polysaccharide
preparations using a modified carbazole assay [34], with
measurement calculated relative to a glucuronolactone standard.
Generation of capsular polysaccharide mutants
Capsular polysaccharide mutants were generated for K.
pneumoniae strains ATCC 43816 and NTUH-K2044 by allelic
exchange mutagenesis by initially PCR-amplifying upstream (59)
and downstream (39) 1 kb fragments from a gene targeted for
knock out (Table 1). The 1 kb homologous fragments were
assembled in pSK (Stratagene) using a HindIII restriction site
common to both the upstream and downstream fragments. A
HindIII floxed zeocin cassette was inserted between the upstream
and downstream fragments before the assembled construct was
moved into an allelic exchange vector, pJMW106, which is a KmR
variant of pCVD442 [35]. Thus, an XbaI-KpnI fragment
containing an in-frame 89.3% coding region deletion of the
NTUH-K2044 wzc gene was cloned into pJMW106, and
electroporated into E. coli strain S17-1 [36] to yield strain S17-
1/pJMW106-NTUH Dwzc::flox-zeo. Similarly, a XhoI-SpeI
fragment containing an in-frame 90.4% coding region deletion
of the ATCC 43816 manC gene was used to generate the strain
S17-1/pJMW106-ATCC DmanC::flox-zeo.
Allelic exchange was conducted over two stages, first by
bacterial conjugation of the allelic exchange vectors from S17-1
to K. pneumoniae and selection of CbRKmR merodiploid
intermediates, and secondly by counter-selection of the suicide
vector with 5% sucrose and zeocin. Confirmation of genome
knock-out mutagenesis was confirmed on KmS clones using PCR
K. pneumoniae Respiratory Disease
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analysis with ‘mut’ primers (Table 1) which flank the deletion site.
The resulting strains were named ATCC DmanC and NTUH
Dwzc.
Microscopic analysis of capsule mutants
Negative staining of K. pneumoniae capsule was conducted
using nigrosin stain, as described elsewhere [37]. Briefly, LB
overnight broth cultures of wild type and capsule mutant strains of
ATCC 43816 and NTUH-K2044 were mixed 1:1 with 10%
nigrosin and smeared onto 18618 mm coverslips. The smear was
air dried before mounting onto a glass slide. Samples were
visualized with a 63x objective on a Zeiss Axio microscope, and
images were analyzed with Zeiss Axiovision Vs40x64 and Imaris
x64 (Bitplane).
Macrophage uptake assay
Both J774A.1 and RAW264.7 cell lines (ATCC) were cultured
in DMEM (Invitrogen) supplemented with heat-inactivated 10%
fetal bovine serum (FBS, HyClone) and seeded into 96 well
microtiter plates at a density of 7.56104 or 26105 cells per well,
respectively. Cells were challenged at an MOI of 10 with K.
pneumoniae ATCC 43816, NTUH-K2044 or MGH 78578, or
with capsule mutants ATCC DmanC or NTUH Dwzc. At one
hour post infection, gentamicin was added to eliminate extracel-
lular bacteria (20 mg/ml final, or 1000 mg/ml for the GmR MGH
78578 strain). Gentamicin concentrations were empirically deter-
mined to kill extracellular K. pneumoniae in DMEM/FBS at .
99.99% efficiency within a 1 hr window. At three hours post
infection, monolayers were washed with PBS, lysed with 0.1%
Triton X-100/PBS for 5 min, and serially diluted for bacterial
enumeration on LB plates. Statistical analysis of data sets was
conducted by One-way ANOVA with Tukey post-test of log-
transformed data.
Macrophage survival assay
J774A.1 and RAW264.7 macrophages were cultured in 96 well
microtiter plates as described above. Triplicate wells of macro-
phages were infected with K. pneumoniae in five replicate plates,
and infections were conducted for 1 hr before the addition of
gentamicin to kill extracellular bacteria, and antibiotic was
maintained throughout the assay duration. At time points
corresponding to 3, 4.5, 6, 9, and 12 hr post infection, a microtiter
plate of samples was washed in PBS before releasing intracellular
bacteria from macrophages using a 5 min treatment of 0.1%
Triton X-100/PBS. Samples were serially diluted in PBS and
plated onto LB plates to enumerate intracellular bacteria.
Statistical analysis of growth between time point outgrowth was
conducted by One-way ANOVA with Tukey post-test of log-
transformed data.
Intratracheal infection of mice
Murine infection studies were approved by the University of
Louisville Institutional Animal Care and Use Committee in
accordance with National Institutes of Health guidelines (Protocol
#10069). Groups of five 8 wk old female BALB/c mice (Charles
River) were challenged using a non-surgical intratracheal infection
procedure was developed to minimize trauma during pathogen
delivery. Intubation-mediated intratracheal (IMIT) inoculations
were conducted as demonstrated in detail elsewhere [38]. Briefly,
isoflurane-anesthetized animals received 10 ml of 2% lidocaine
anesthetic to the rear of the throat and were supported supine on a
tilting platform raised to a 45u angle. Using a fine tipped cotton
applicator, the tongue was retracted while an otoscope fitted with a
cut-away specula was inserted into the oral cavity to visualize the
glottis. An 18 G catheter, cast with a silicone rubber sleeve (10 mm
of catheter exposed) was used to intubate mice, using a 20 mil
guide wire to assist catheter placement. A 20 G blunt needle was
used to instill a 50 ml PBS bacterial suspension directly into the
lung via the catheter, followed by a 150 ml volume of air to aid
distribution of the inoculum. Infected animals were monitored
twice daily for indications of moribund disease, at which point they
were humanely euthanized by isoflurane. Studies were concluded
at 14 days. Statistical analysis of survival data was conducted using
Log-rank (Mantel-Cox) and Gehan-Breslow-Wilcoxon Tests
(GraphPad Prism 5). Probit analysis (StatPlus 2009 Professional)
was used to calculate the LD50 (Lethal Dose 50%) and both the
upper (UCL) and lower (LCL) reliable interval values.
Bacterial enumeration from key sites of infection
Groups of five BALB/c mice were infected using the IMIT
model with 102.2 CFU of either NTUH-K2044 or ATCC 43816.
Moribund mice were euthanized at the presentation of lethargy,
hunching, and labored breathing. Mice were euthanized by
overdose of isoflurane, immediately followed by exsanguination by
cardiac puncture with a 23 G needle, and the blood was collected
to a Microtainer (K2EDTA, BD Biosciences). Lung, liver and
spleen were each collected into a sterile Whirl-Pak bag (Nasco) and
Table 1. Primers used in this study.
59 ATCC manC XbaI(+) CTGCTCGAGATTACCAAAGATATCTTCACCAAGAAGGATGAAG
59 ATCC manC HindIII(2) GTAAAGCTTGCGAGACATCGGCCAGAGACGAC
39 ATCC manC HindIII(+) GAAAAGCTTGAGATCCAGTCGGGGTCGTACCTC
39 ATCC manC KpnI(2) GTGACTAGTTTTCGCTCCCGGCTGCTTCTGC
ATCC manC mut(+) GTTATTCTACAATAAACTGACCAAGTCATCTTGTTTCCTCTCCTTCG
ATCC manC mut(2) CTATCTTCCCGGGTTTCAGAAATTCGCCGTAGGC
59 NTUH wzc XbaI(+) CGTTCTAGAGCATAACGGTAAAGATACTAAGATCTCCTTATATGC
59 NTUH wzc HindIII(2) CAAAGCTTTATGATCAATAACTTCACCAATTAAACGACCTAGATCGATCC
39 NTUH wzc HindIII(+) CAAAGCTTTCGATGTTGCTAAAAATAGATTGGAACATAGCGGTGTTATAG
39 NTUH wzc KpnI(2) CTGGTACCTAATAATGAGGAGAACATTACCATAAAACGAGATGTATTTCG
NTUH wzc mut(+) GGCAAAACTATGTTATTCGGACATTGGATAGGGCAACGAG
NTUH wzc mut(2) CATTAATCGCAAGGCCAAATCCTTGTGATAATAGCATGCTTAGTATTC
doi:10.1371/journal.pone.0107394.t001
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homogenized in 1 ml of sterile PBS, by rolling the tissue with a
25 ml serological pipette. Blood and tissue homogenate were
subjected to detergent lysis with 1% Triton X-100 for 5 min and
subsequently serially diluted in a 96 well plate. LB plates were
spot-plated with 10 ml aliquots of diluted bacterial suspensions,
grown for 8 hrs at 37uC, and bacterial burdens were calculated
based on dilution factor, tissue weight, and estimated tissue
density. Neutral buoyancy testing in glycerol solutions revealed
that the estimated tissue densities for lung, liver, and spleen were
1.03, 1.08, and 1.06 g/ml, respectively.
Results
Whole genome sequencing of strain ATCC 43816
K. pneumoniae ATCC 43816 is a well-studied strain, capable of
causing a moribund respiratory disease in mouse models.
However, limited genomic data is available to support future
investigations of K. pneumoniae pathogenesis, thus we decided to
perform whole genome sequencing. Next Generation Sequencing
was used to sequence the ATCC 43816 genome, which was
subsequently assembled into 1763 contigs consisting of 4.207 MB
of sequence data (accession number APWN00000000). To
investigate the genetic relatedness of sequenced K. pneumoniae
strains, the ATCC 43816 genome was aligned to the complete
genome sequences of the NTUH-K2044 and MGH 78578 strains
(Figure 1A and B, respectively). A total of 1676 contigs (4.128 MB)
aligned with the NTUH-K2044 chromosome representing 78.7%
genome coverage. Similarly, 1668 contigs (4.098 MB) mapped to
77.1% of the MGH 78578 genome, which includes two contigs
mapping to the toxin-antitoxin system of the pKPN4 plasmid. We
identified no additional sequence homology to K. pneumoniae
plasmids, and the homologous toxin-antitoxin system is main-
tained on the chromosome for the NTUH-K2044 strain,
suggesting that K. pneumoniae strain ATCC 43816 does not
possess plasmids.
A high degree of genetic conservation was observed between the
three K. pneumoniae strains with 96.3% of ATCC 43816 sequence
mapping to both MGH 78578 and NTUH-K2044. However,
69.71 kb of ATCC 43816 contigs uniquely map with the NTUH-
K2044 genome and 44.67 kb with the MGH 78578 genome
(1.66% and 1.06% total sequence data, respectively). While MGH
78578 shares primarily metabolic and hypothetical proteins with
ATCC 43816, NTUH-K2044 shares the virulence-associated
yersiniabactin biosynthetic operon, a Type IV secretion system, an
iron transport system, a CRISPR locus, and an acetonin
catabolism locus (Table 2). Given the conservation of known
virulence determinants between ATCC 43816 and NTUH-
K2044, the data suggests that NTUH-K2044 may share the same
virulence potential as ATCC 43816 in disease models. Conversely,
MGH 78578 lacks several of the virulence determinants previously
identified as critical to the disease potential of ATCC 43816 in
murine respiratory disease models, suggesting that MGH 78578
may have a reduced virulence in these models, though MGH
78578 is notably a clinical lung isolate from a presentation of
pneumonia.
We also identified novel genetic sequences unique to ATCC
43816, and not present in either NTUH-K2044 or MGH 78578,
notably including two bacteriophages, one of which is homologous
to a bacteriophage found in the enteric Escherichia coli strain
UMN026, and the other to the upper respiratory tract (URT)
pathogen Klebsiella rhinoscleromatis strain ATCC 13884 (Ta-
ble 2). Little has been reported regarding the clinical history of
ATCC 43816, however the presence of both gastrointestinal (GI)
and URT-related bacteriophages suggests that this K. pneumoniae
strain may have previously been resident of both host niches.
Next Generation Sequencing provided an estimated 78%
coverage of the ATCC 43816 genome, however sequencing of
the capsular polysaccharide biosynthetic locus was under-repre-
sented at 22% coverage (determined retrospectively). Given the
importance of capsule as a virulence determinant, we completed
sequencing of a 34.6 kb region which includes the capsule locus as
well as an adjacent region (wzm to wbbO) reported to be required
for LPS biosynthesis (Fig. 2) [39]. The K2 capsular polysaccharide
locus shares broad homology to sequenced capsule loci from the
galF to wzc and rfbP to uge genes, but shares specific homology
over the central orf7 to orf13 genes to a subset of sequenced K.
pneumoniae strains of K2 serotype. Homology over the entire
capsule locus is therefore highest (99% identity) to that of the
recently fully sequenced strains CG43 (Accession CP006648),
KCTC 2242 (CP002910), and Kp52.145 (FO834906), and also to
the partially sequenced capsule biosynthetic loci of VGH525
(Accession AB371296) and Chedid (D21242). The central region
of the capsule loci encodes for the antigenic diversity of capsules,
which has previously supported the use of PCR as a methodology
to identify capsule serotype [40,41].
Characterization of capsule production
K. pneumoniae capsular serotypes influence the virulence
potential of strains, as could the regulated production of capsule.
Thus, we investigated whether differences exist in the amount of
capsule produced by the three clinical strains examined in this
study. K. pneumoniae were examined for their ability to produce
capsule from LB overnight cultures. We found that ATCC 43816,
NTUH-K2044 and MGH 78578 strains produced 9.7, 13.5, and
6.1 fg/CFU of capsule, respectively. As a control, we also
measured capsule production from previously characterized strain
52.145 which produced 21.7 fg/CFU of capsule in our studies,
consistent with 52.145 being a significant producer of capsule [33].
Our measurement of NTUH-K2044 capsule production is
consistent with previously reported levels of 17.3 fg/CFU of
capsule from overnight LB cultures [42]. Thus, of the sequenced
strains studied in this work, NTUH-K2044 produced the greatest
amount of capsule at levels 1.4 and 2.2 fold greater than ATCC
43816 and MGH 78578. Similar amounts of capsule were
measured from strains grown to mid-exponential phase in TSBDC
(data not shown), suggesting that media and growth phase do not
significantly impact capsule production.
Cell culture model
K. pneumoniae is internalized by a variety of host cell types both
in vivo and in cell culture models, thus we investigated whether
the three study strains exhibit differences in uptake rates in
cultured murine macrophages. Given that capsular polysaccharide
has been reported to mediate an antiphagocytic phenotype, we
also generated capsular polysaccharide mutants of ATCC 43816
(DmanC) and NTUH-K2044 (Dwzc), and confirmed that the
capsule mutants exhibited reduced exclusion of nigrosin staining
(Figure 3). Both J774A.1 and RAW264.7 monolayers were
challenged with K. pneumoniae strains at an MOI of 10, and
internalized bacteria were detected using a gentamicin protection
assay. In both J774A.1 and RAW264.7 cells, the MGH 78578
strain was phagocytosed more efficiently than the ATCC 43816
and NTUH-K2044 strains (P,0.001) (Figure 4). This suggests
that the K52 serotype capsule of the MGH 78578 strain does not
resist uptake by murine macrophages to the same degree as
representative K1 and K2 serotype strains. In addition, ATCC
43816 was phagocytosed more efficiently than NTUH-K2044 in
K. pneumoniae Respiratory Disease
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Figure 1. Alignment of the ATCC 43816 sequence to previously sequenced K. pneumoniae chromosomes. Next generation sequencing
of ATCC 43816 produced 1763 contigs which were aligned to published NTUH-K2044 (Panel A) and MGH 78578 (Panel B) chromosomes. The
locations of the contigs are shown as long green lines. The two outer tracks depict the annotated genes in the reference genomes (on both strands)
while the two inner tracks show GC content and GC skew, respectively which strongly effects sequencing as can be seen from the coincidence of low
GC content regions and gap in the contig alignments.
doi:10.1371/journal.pone.0107394.g001
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both cell lines (P,0.001), suggesting that there may be differences
in the antiphagocytic properties of K1 and K2 capsular
polysaccharides or other surface exposed factors.
We therefore also investigated whether capsule alone mediates
the antiphagocytic phenotype by comparing ATCC 43816 and
NTUH-K2044 capsule mutants to relatively highly phagocytosed
MGH 78578. Both ATCC DmanC and NTUH Dwzc capsule
mutants were phagocytosed at significantly higher rates than their
isogenic wild type parent strains in both cell lines (Figure 4), and
furthermore, the NTUH Dwzc was significantly less phagocytosed
than the MGH 78578 strain. These data demonstrate that the
NTUH Dwzc capsule mutant retains antiphagocytic properties
which are distinct from capsular polysaccharide, suggesting that
additional factors additionally mediate the antiphagocytic pheno-
type of K. pneumoniae. The ATCC DmanC was phagocytosed at
levels similar to the MGH 78578 K52 strain, and it is therefore not
possible to conclude whether ATCC 43816 possesses non-capsule
antiphagocytic determinants using the K52 MGH 78578 strain
which may itself be antiphagocytic. Due to the intrinsic antibiotic
resistance of the MGH 78578 strain to common antibiotic markers
used for molecular biology, we were unable to generate an
acapsular MGH 78578 strain for these studies.
We decided to investigate whether K. pneumoniae is replication-
competent within cultured macrophages after internalization. Both
RAW264.7 and J774A.1 murine macrophages were infected at an
MOI of 10 with subsequent evaluation of bacterial colonization at
time points 3, 4.5, 6, 9 and 12 hr post infection. As observed
previously, MGH 78578 was internalized at the highest levels in
both cell lines, while NTUH-K2044 had the lowest level of
internalization at the 3 hr time point (Figure 5). Proliferation of K.
pneumoniae was observed for all bacterial strains, however during
9 hr of observation between the 3 and 12 hr time points the
average fold increase in bacterial number was just 3.0–4.6 fold in
J774A.1 cells. Higher rates of proliferation were observed for
ATCC 43816 and MGH 78578 in RAW264.7 cells, however
NTUH-K2044 saw only a 2.9 fold increase in bacterial numbers
from 3 hr to 12 hr. These data indicate that the K1 (NTUH-
K2044) and K2 (ATCC 43816) strains of K. pneumoniae are
internalized at relatively low rates but are replication competent in
cultured macrophages. However, the K52 strain, MGH 78578,
was phagocytosed at relatively high levels in both cell lines, and
proliferated significantly in RAW264.7 cells. Importantly, intra-
cellular ATCC 43816 and MGH 78578 exhibited significant
outgrowth in cultured macrophages between the 3 and 12 hr time
Table 2. Genetic elements common/unique to sequenced strains.
Genetic loci common to NTUH-K2044 Genes mapped (KP1_)
Yersiniabactin biosynthesis 3583–3586, 3588–3593, 3605–3609, 3611–3613
Type IV Secretion 3634, 3638–3641, 3643
Iron transport 1980–1989
CRISPR locus 3164–3166, 3171
Acetonin catabolism 1112–1121
Conserved and hypothetical genes 2362–2364, 2378–2385, 3239–3240, 3773
Genetic loci common to MGH 78578 Genes mapped (KPN_)
Metabolic 00033–00034, 00594–00598, 03359–03370, 03372, 04612–04613
Conserved and hypothetical genes 01146–01148, 01151–01164, 01432–01433, 01316–01317, 04518
ATCC 43816 genetic loci absent from NTUH-K2044 and MGH 78578 Genes
Escherichia coli UMN026-like bacteriophage ECUMN_0964–0965, 0975, 0977–0986, 0994–0996
Klebsiella pneumoniae subsp. rhinoscleromatis ATCC 13884-like bacteriophage HMPREF0484_4775, 4777–4779, 1182
Enterobacter radicincitans DSM 16656 acriflavine resistance Y71_5381–5385
Klebsiella oxytoca 10–5243 fimbrial biosynthesis HMPREF9687_02419–02420
Hypothetical protein Salmonella enterica subsp. enterica serovar Saintpaul str. SARA29 SeSPB_A4698
Hypothetical protein Enterobacter hormaechei ATCC 49162 HMPREF9086_3347
Hypothetical protein Klebsiella sp. 4_1_44FAA HMPREF1024_04074
Hypothetical protein Escherichia hermannii NBRC 105704 EH105704_01_06400
doi:10.1371/journal.pone.0107394.t002
Figure 2. Genetic organization of the ATCC 43816 K2 capsule locus. Scale representation of the capsular polysaccharide biosynthetic locus
(galF-uge) and LPS locus (wzm-yvet). The central domain of the capsule locus (orf7-orf13) represents the antigenic diversity region unique to K2
serotype capsules, while the remainder of the locus is well conserved with other K. pneumoniae capsule loci.
doi:10.1371/journal.pone.0107394.g002
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points (both J774A. 1 and RAW264.7, P,0.001), indicating that
K. pneumoniae possesses replicative viability within macrophages,
in spite of its classification as an extracellular pathogen. These data
suggest that differences between K. pneumoniae serotype, and
potentially other genetic determinants, could impact the preferred
host niche during disease, including the propensity to persist
within macrophages.
Respiratory murine model of K. pneumoniae infection
We decided to investigate the virulence potential of the three
sequenced K. pneumoniae strains in a murine respiratory disease
model. Because K. pneumoniae is known to colonize the upper
respiratory tract (URT) in mammals, we developed a novel
infection model to deliver K. pneumoniae non-surgically into the
lung of mice using intubation-mediated intratracheal (IMIT)
instillation, specifically modeling lower respiratory tract (LRT)
disease. Female BALB/c mice were challenged with one of the
three K. pneumoniae study strains using the IMIT infection
method using multiple challenge doses to estimate the 50% lethal
dose (LD50). Both ATCC 43816 and NTUH-K2044 were found
to be highly virulent strains of K. pneumoniae (LD50,100) while
the MGH 78578 strain is significantly less virulent, with an LD50.
105.4 fold higher than the virulent strains (Table 3). K. pneumoniae
respiratory disease in the IMIT mouse model is associated with an
acute course of disease with minimally lethal doses resulting in
moribund disease within 3–4 days (Figure 6).
Groups of mice infected with minimally lethal doses of ATCC
43816 and NTUH-K2044 (102.2 CFU) were necropsied to
investigate bacterial burdens in host tissues. Bacteria were
enumerated by plate count from blood, and homogenates of lung,
liver, and spleen. Moribund mice were found to have the highest
levels of host colonization in both blood and lung, followed by liver
and spleen (Figure 7). One-way ANOVA with Tukey Post Test
revealed no significant difference between ATCC 43816 and
NTUH-K2044 bacterial burdens in any of the host samples
examined. These data reveal that both ATCC 43816 and NTUH-
K2044 K. pneumoniae pneumonia is associated with development
of a significant bacteremia and systemic spread to multiple organs.
Figure 3. Negative staining of capsular polysaccharide from
ATCC 43816 and NTUH-K2044 strains. Overnight bacterial
suspensions of ATCC 43816 (A), ATCC DmanC (B), NTUH-K2044 (C)
and NTUH Dwzc (D) were mixed in 1:1 ratio with 10% nigrosin. The loss
of the capsular polysaccharide from the mutant strains were illustrated
by the decrease exclusion of the nigrosin dye which was visualized with
Zeiss Axio microscope (63x magnification). Imaris analysis identified
that the cross-sectional areas of ATCC DmanC, and NTUH Dwzc mutants
were reduced by 36.21%, and 28.59%, relative to their isogenic parents.
doi:10.1371/journal.pone.0107394.g003
Figure 4. Uptake of K. pneumoniae wild type and capsular polysaccharide mutants strains into cultured murine macrophages. K.
pneumoniae strains ATCC 43816 (K2), NTUH-K2044 (K1) and MGH 78578 (K52) or capsule mutants ATCC DmanC, and NTUH Dwzc were incubated in
the presence of cultured murine macrophage cell lines J774A.1 or RAW264.7 at an MOI of 10 in 96 well plates. At one hour post-infection, gentamicin
was introduced to eradicate extracellular bacteria, and uptake of K. pneumoniae strains into macrophages was assessed at 3 hr post-infection by plate
counting. Triplicate samples were enumerated and data analyzed as a percentage of the inoculum, with the results representative of at least two
independent trials.
doi:10.1371/journal.pone.0107394.g004
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Discussion
K. pneumoniae respiratory infections may result from several
mechanisms of pathogen introduction into susceptible hosts
including inhalation of environmental sources of bacteria, as it
relates to community acquired pneumonia (CAP), or nosocomial
foreign body introduction of K. pneumoniae into the respiratory
system, as in ventilator associated pneumonia (VAP). Thus,
respiratory infections with K. pneumoniae are clinically important
both to nosocomial pneumonia in hospital settings as well as CAP
in developing areas of the world. The primary focus of this work
was to gain insight into the molecular mechanisms which
contribute to the respiratory disease caused by virulent K.
pneumoniae. We therefore sequenced one of the commonly
researched strains, capable of causing pneumonia in surrogate
animal models. The ATCC 43816 strain was successfully
sequenced by Next Generation approaches at approximately
80% coverage, based on estimated total sequence data relative to
the NTUH-K2044 genome size. The majority of ATCC 43816
sequence (.96%) was well conserved to both the highly virulent
NTUH-K2044 and the minimally virulent MGH78578 strains
suggesting that K. pneumoniae strains may have large core
genomes, and that key differences in virulence potential may be
related to a small number of pathogenicity islands.
Based on the data from our murine respiratory disease model,
we identified NTUH-K2044 and ATCC 43816 as highly virulent
K. pneumoniae strains, and MGH 78578 as a low virulence strain.
These findings are consistent with clinical evidence that K1 and
K2 serotypes of K. pneumoniae are most commonly associated
with severe disease presentations, including CAP, invasive
presentations, as well as lethality in a mouse intravenous challenge
model [7,43]. To the best of our knowledge, this current study
provides the first experimental evidence demonstrating that a
representative K52 clinical isolate is relatively avirulent in a
murine respiratory disease model. Thus, phenotypic evidence links
the newly sequenced ATCC 43816 strain to the fully sequenced
NTUH-K2044 rather than MGH 78578 strain. The genetic
systems found to be shared between NTUH-K2044 and ATCC
43816, but absent from MGH 78578 included iron acquisition
genes (yersiniabactin biosynthesis and iron transport), a Type
4 secretion system (T4SS), a CRISPR locus, and an acetonin
catabolism locus. Yersiniabactin biosynthetic operon has been
previously demonstrated to be important to the function of ATCC
43816 in a murine intranasal respiratory disease model [16,17],
where yersiniabactin is thought to contribute to evasion of the
activity of lipocalin2 in the lung – a host factor which neutralizes
enterobactin-based iron acquisition [44]. The T4SS present in the
virulent ATCC 43816 and NTUH-K2044 strains has been
proposed to potentially represent a DNA conjugation system,
and is also present in the related K. variicola environmental isolate
strain 342 [45,46], thus future studies will be required to
investigate the virulence potential of this secretion system in K.
pneumoniae. This study supports previous findings that the
capsular serotype and the presence of the yersiniabactin iron
acquisition systems contribute significantly to the disease potential
of highly virulent K. pneumoniae strains, with the additional
possibility that T4SS or acetonin catabolism may be important for
K. pneumoniae disease.
In this study, we investigated whether there were any significant
differences in the ability of K. pneumoniae strains to persist within
cultured macrophages. K. pneumoniae is considered to be
primarily an extracellular pathogen, although there is evidence
that this organism may be internalized in human epithelial cell
lines [47,48]. Furthermore, K. pneumoniae can be taken up into
cultured murine peritoneal macrophages, and are also internalized
in vivo in alveolar macrophages [49]. However, capsular polysac-
Figure 5. Growth potential of K. pneumoniae strains in cultured murine macrophages. K. pneumoniae strains ATCC 43816 (K2), NTUH-K2044
(K1) and MGH 78578 (K52) were incubated in the presence of cultured murine macrophage cell lines J774A.1 or RAW264.7 at an MOI of 10 in 96 well
plates. At one hour post-infection, gentamicin was introduced to eradicate extracellular bacteria. At 3, 4.5, 6, 9, and 12 hr post-infection, a triplicate
set of samples was processed for enumeration of intracellular bacteria. The data is representative of at least three independent trials.
doi:10.1371/journal.pone.0107394.g005
Table 3. Probit analysis of IMIT-infections of BALB/c mouse using K. pneumoniae strains.
Strain LD50 (95% CI*)
ATCC 43816 4.716101 (1.36610121.636102)
NTUH-K2044 2.336101 (5.4610021.016102)
MGH 78578 1.376107 (9.50610621.976107)
*95% confidence interval.
doi:10.1371/journal.pone.0107394.t003
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charide may mediate blocking the initial attachment of bacteria to
cells, reducing internalization [50]. Given the importance of
capsule in mediating the uptake of K. pneumoniae into phagocytic
cells, we anticipated that the representative K2 strain in our study,
ATCC 43816, may resist uptake into cultured macrophages given
the previous discovery that the K2 serotype is associated with an
absence of mannose residues in the capsular polysaccharide [51].
Similarly, the gmd and wcaG genes, present in K1 serotype
capsular loci, are required for the modification of mannose to
fucose, and a corresponding low level of mannose/high level
fucose in K. pneumoniae isolates which possess these genes [52].
We had observed that the K1 strain NTUH-K2044 exhibited
particularly low uptake into cultured murine macrophages in our
studies, and that the K2 strain ATCC 43816 also had a lower level
of uptake than the K52 strain MGH78578. Similarly, capsule has
been demonstrated to mediate anti-phagocytosis in both amoeba
and alveolar macrophages, suggesting that this role for capsule is
ubiquitously important across a range of host-pathogen interac-
tions with professional phagocytes [21,53]. Given the potential
role of the mannose receptor in facilitating phagocytosis, and the
reduced level of mannose residues in K1 and K2 serotype
capsules, it is possible that modulation of the polysaccharide
surface of K. pneumoniae may represent an important strategy for
evading host defense.
Consistent with prior studies, we found that acapsular K.
pneumoniae mutants also exhibited increased uptake into macro-
phages, however, we also observed that the increase in uptake of
the NTUH-K2044 capsule mutant did not achieve the level of
uptake of the representative K52 serotype strain. This finding
suggests that the NTUH-K2044 strain possesses additional non-
capsule antiphagocytic factors, or that the MGH78578 strain
actively promotes its uptake into macrophages. Given that K.
pneumoniae capsule does possess antiphagocytic properties as a
strategy to act primarily as an extracellular pathogen, we
hypothesize that the K52 MGH 78578 strain does not promote
its own uptake, and instead, we hypothesize that the function of
Figure 6. Survival analysis of K. pneumoniae respiratory challenge. Groups of five female BALB/c mice were challenged with K. pneumoniae
strains ATCC 43816 (K2), NTUH-K2044 (K1) or MGH 78578 (K52) by IMIT respiratory infection. Mice were monitored for 14 days, and moribund mice
were euthanized. The challenge dose for each survival curve group is indicated.
doi:10.1371/journal.pone.0107394.g006
Figure 7. Bacterial burden of K. pneumoniae-infected mice. Groups of five female BALB/c mice were infected with K. pneumoniae strains ATCC
43816 or NTUH-K2044 and tissues were harvested at the onset of moribund disease, and homogenized in 1 ml of PBS Bacteria were enumerated from
blood and from homogenates of lung, liver, and spleen. The results present a min/max box and whisker plot for each infected tissue (n = 5). Statistical
analysis was carried out by one way ANOVA and Tukey post test.
doi:10.1371/journal.pone.0107394.g007
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K52 capsules would be as an antiphagocytic determinant
consistent with other serotype capsules. Thus, we interpret that
the NTUH-K2044 strain possesses multiple mechanisms to resist
phagocytosis, which is consistent with previous findings that
capsule, LPS, carnitine metabolism, and the ClpX protease are all
required to resist entry into amoeba and human neutrophils [53].
We conclude that K. pneumoniae antiphagocytosis is mediated by
a multifactorial process and that capsule alone is insufficient to
account for this phenotype. This conclusion is consistent with prior
published findings that additional genetic loci participate in
mediating K. pneumoniae antiphagocytosis, including genes for
LPS, the ClpX protease, and carnitine metabolism [53].
In our respiratory challenge studies, the K1 and K2 serotype
strains possessed a significantly higher virulence in mice than the
K52 serotype strain, supporting the possibility that evasion of
phagocytosis is a strategy employed by K. pneumoniae to enhance
virulence in mammalian hosts. Thus, these finding support the
characterization of K. pneumoniae as an extracellular pathogen,
whereby the most virulent strains are also the most antiphagocytic.
These results are consistent with previous reports which have
demonstrated that antiphagocytic properties of K. pneumoniae
capsule are associated with highly virulent K1 and K2 serotypes in
panels of Asian strain isolates [54,55]. It is however noteworthy
that several additional virulence-associated genetic determinants
are common to the K1 and K2 representative strains investigated
in this study, including mechanisms of iron acquisition, highlight-
ing that K. pneumoniae serotype is not the sole distinguishing
factor for predicting disease potential in mammalian hosts.
Our data supports a link between evasion of phagocytosis and
virulence potential as an interpretation that K. pneumoniae is
primarily an extracellular pathogen. However, we interestingly
demonstrate that K. pneumoniae strains are fit to replicate within
macrophages once internalized. This is an intriguing finding that
may suggest that a subpopulation of K. pneumoniae may use an
intracellular lifestyle as part of the disease process. Future studies
will be required to characterize to what extent K. pneumoniae has
adapted to intracellular host-pathogen interaction, and what role
the intracellular lifestyle might play in vivo.
We developed a novel respiratory disease model to study K.
pneumoniae pneumonia which facilitated an investigation of the
lower respiratory tract (LRT) colonization in the absence of the
involvement of other primary sites of infection. Our motivation to
develop this model system was in part shaped by our observations
that bacterial pathogens may opportunistically infect the upper
respiratory tract (URT) in a process which is unique from that
observed during human disease [56]. Direct non-surgical instilla-
tion directly into the LRT also directly mimics a normal route of
nosocomial acquisition of K. pneumoniae associated with VAP.
Our novel intubation-mediated intratracheal (IMIT) delivery of
bacteria facilitates: i) the use of a flow meter to validate the
placement of a catheter into the trachea, ii) the ability to instill
bacteria directly into the lung via a blunt needle inserted through
the catheter lumen, iii) delivery of bacteria into the lower lobes of
the lung under positive pressure, and iv) minimal trauma to the
host owing to the non-surgical nature of the procedure.
We found that our novel IMIT infection model lowered
previously reported LD50 values for both i.n. and surgical i.t.
infection models, suggesting that targeted delivery of a reduced
number of bacteria to the lungs enhances the disease potential of
K. pneumoniae. The LD50 for the ATCC 43816 strain in the
IMIT model is 101.8–102.8 fold less than previously published LD50
values using intranasal models [16,57,58], suggesting that the
IMIT model provides a lower LD50 due to the ability of the
intubation tubing to briefly occlude the air space, allowing for
positive pressure delivery of organisms deep into the lung, rather
than passive delivery into the lung in shallowly breathing
anesthetized animals. Thus, our IMIT model improves the disease
potential of K. pneumoniae in lung-specific disease, and may be an
excellent instillation method for therapeutic and diagnostic
reagents in studies requiring LRT delivery.
In summary, our study has provided a first draft sequence of the
ATCC 43816 genome which will support future investigations of
K. pneumoniae function. We also have provided the first
description of the growth potential of K. pneumoniae in cultured
murine macrophages, supporting a growing body of evidence that
K. pneumoniae may not be exclusively an extracellular pathogen.
Finally, we have developed and employed a novel non-surgical,
lung-specific infection model which allows for targeted low dose
inoculation of K. pneumoniae giving rise to a lethal pneumonia in
mice, and revealing a significant difference in the disease potential
of clinical isolates.
Acknowledgments
We would like to thank Dr. Matthew Lawrenz for critical review of this
manuscript.
Author Contributions
Conceived and designed the experiments: JMW. Performed the experi-
ments: JBS RAF HT PY TLP JMW. Analyzed the data: JBS RAF HT PY
RB JMW. Contributed reagents/materials/analysis tools: PY RB JMW.
Wrote the paper: RB JMW.
References
1. Bagley ST (1985) Habitat association of Klebsiella species. Infect Control 6: 52–
58.
2. Kesteman AS, Perrin-Guyomard A, Laurentie M, Sanders P, Toutain PL, et al.
(2010) Emergence of resistant Klebsiella pneumoniae in the intestinal tract during
successful treatment of Klebsiella pneumoniae lung infection in rats. Antimicro-
bial agents and chemotherapy 54: 2960–2964.
3. Highsmith AK, Jarvis WR (1985) Klebsiella pneumoniae: selected virulence
factors that contribute to pathogenicity. Infect Control 6: 75–77.
4. Chung DR, Song JH, Kim SH, Thamlikitkul V, Huang SG, et al. (2011) High
prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia
in Asia. American journal of respiratory and critical care medicine 184: 1409–
1417.
5. Paganin F, Lilienthal F, Bourdin A, Lugagne N, Tixier F, et al. (2004) Severe
community-acquired pneumonia: assessment of microbial aetiology as mortality
factor. The European respiratory journal: official journal of the European
Society for Clinical Respiratory Physiology 24: 779–785.
6. Podschun R, Ullmann U (1998) Klebsiella spp. as nosocomial pathogens:
epidemiology, taxonomy, typing methods, and pathogenicity factors. Clinical
microbiology reviews 11: 589–603.
7. Yu VL, Hansen DS, Ko WC, Sagnimeni A, Klugman KP, et al. (2007)
Virulence characteristics of Klebsiella and clinical manifestations of K.
pneumoniae bloodstream infections. Emerging infectious diseases 13: 986–993.
8. Marrie TJ, Durant H, Yates L (1989) Community-acquired pneumonia
requiring hospitalization: 5-year prospective study. Reviews of infectious diseases
11: 586–599.
9. Fang GD, Fine M, Orloff J, Arisumi D, Yu VL, et al. (1990) New and emerging
etiologies for community-acquired pneumonia with implications for therapy. A
prospective multicenter study of 359 cases. Medicine 69: 307–316.
10. Marston BJ, Plouffe JF, File TM Jr, Hackman BA, Salstrom SJ, et al. (1997)
Incidence of community-acquired pneumonia requiring hospitalization. Results
of a population-based active surveillance Study in Ohio. The Community-Based
Pneumonia Incidence Study Group. Archives of internal medicine 157: 1709–
1718.
11. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, et al. (2008) NHSN
annual update: antimicrobial-resistant pathogens associated with healthcare-
associated infections: annual summary of data reported to the National
Healthcare Safety Network at the Centers for Disease Control and Prevention,
2006–2007. Infection control and hospital epidemiology: the official journal of
the Society of Hospital Epidemiologists of America 29: 996–1011.
K. pneumoniae Respiratory Disease
PLOS ONE | www.plosone.org 10 September 2014 | Volume 9 | Issue 9 | e107394
12. CDC (2009) Guidance for control of infections with carbapenem-resistant or
carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR
Morbidity and mortality weekly report 58: 256–260.
13. Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ (1993) Nosocomial
outbreak of Klebsiella infection resistant to late-generation cephalosporins.
Annals of internal medicine 119: 353–358.
14. Doyle T, Sanderson R (2008) Survey of hospital microbiology laboratories
regarding Klebsiella pneumoniae carbapenemase (KPC)-producing organisms.
Epi Update: Florida Department of Health: 9–12.
15. Marquez P, Terashita D (2010) Carbapenem-resistant Klebsiella pneumoniae
(CRKP) surveillance Los Angeles County, June-December 2010. Special Studies
Report: LA County Public Health: 25–26.
16. Lawlor MS, Hsu J, Rick PD, Miller VL (2005) Identification of Klebsiella
pneumoniae virulence determinants using an intranasal infection model. Mol
Microbiol 58: 1054–1073.
17. Lawlor MS, O’Connor C, Miller VL (2007) Yersiniabactin is a virulence factor
for Klebsiella pneumoniae during pulmonary infection. Infect Immun 75: 1463–
1472.
18. Lavender HF, Jagnow JR, Clegg S (2004) Biofilm formation in vitro and
virulence in vivo of mutants of Klebsiella pneumoniae. Infection and immunity
72: 4888–4890.
19. Padilla E, Llobet E, Domenech-Sanchez A, Martinez-Martinez L, Bengoechea
JA, et al. (2010) Klebsiella pneumoniae AcrAB efflux pump contributes to
antimicrobial resistance and virulence. Antimicrobial agents and chemotherapy
54: 177–183.
20. March C, Moranta D, Regueiro V, Llobet E, Tomas A, et al. (2011) Klebsiella
pneumoniae outer membrane protein A is required to prevent the activation of
airway epithelial cells. The Journal of biological chemistry 286: 9956–9967.
21. March C, Cano V, Moranta D, Llobet E, Perez-Gutierrez C, et al. (2013) Role
of bacterial surface structures on the interaction of Klebsiella pneumoniae with
phagocytes. PLoS ONE 8: e56847.
22. Insua JL, Llobet E, Moranta D, Perez-Gutierrez C, Tomas A, et al. (2013)
Modeling Klebsiella pneumoniae pathogenesis by infection of the wax moth
Galleria mellonella. Infection and immunity 81: 3552–3565.
23. Izquierdo L, Coderch N, Pique N, Bedini E, Corsaro MM, et al. (2003) The
Klebsiella pneumoniae wabG gene: role in biosynthesis of the core lipopolysac-
charide and virulence. Journal of bacteriology 185: 7213–7221.
24. Wu KM, Li LH, Yan JJ, Tsao N, Liao TL, et al. (2009) Genome sequencing and
comparative analysis of Klebsiella pneumoniae NTUH-K2044, a strain causing
liver abscess and meningitis. J Bacteriol 191: 4492–4501.
25. Liu P, Li P, Jiang X, Bi D, Xie Y, et al. (2012) Complete genome sequence of
Klebsiella pneumoniae subsp. pneumoniae HS11286, a multidrug-resistant strain
isolated from human sputum. Journal of bacteriology 194: 1841–1842.
26. Shin SH, Kim S, Kim JY, Lee S, Um Y, et al. (2012) Complete genome
sequence of the 2,3-butanediol-producing Klebsiella pneumoniae strain KCTC
2242. Journal of bacteriology 194: 2736–2737.
27. Chou HC, Lee CZ, Ma LC, Fang CT, Chang SC, et al. (2004) Isolation of a
chromosomal region of Klebsiella pneumoniae associated with allantoin
metabolism and liver infection. Infect Immun 72: 3783–3792.
28. Cano V, Moranta D, Llobet-Brossa E, Bengoechea JA, Garmendia J (2009)
Klebsiella pneumoniae triggers a cytotoxic effect on airway epithelial cells. BMC
Microbiol 9: 156.
29. Brett PJ, Deshazer D, Woods DE (1997) Characterization of Burkholderia
pseudomallei and Burkholderia pseudomallei-like strains. Epidemiol Infect 118:
137–148.
30. Zerbino DR, Birney E (2008) Velvet: algorithms for de novo short read assembly
using de Bruijn graphs. Genome research 18: 821–829.
31. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, et al. (1997) Gapped
BLAST and PSI-BLAST: a new generation of protein database search
programs. Nucleic acids research 25: 3389–3402.
32. Scott JB (2013) Genetic characterization of the K2 serotype capsule of Klebsiella
pneumoniae ATCC 43816 and the development of a bioluminescent strain.
Louisville: University of Louisville.
33. Campos MA, Vargas MA, Regueiro V, Llompart CM, Alberti S, et al. (2004)
Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides.
Infect Immun 72: 7107–7114.
34. Bitter T, Muir HM (1962) A modified uronic acid carbazole reaction. Analytical
biochemistry 4: 330–334.
35. Donnenberg MS, Kaper JB (1991) Construction of an eae deletion mutant of
enteropathogenic Escherichia coli by using a positive-selection suicide vector.
Infect Immun 59: 4310–4317.
36. Simon R, Priefer U, Pu¨hler A (1983) A broad range mobilization system for
in vivo genetic engineering: transposon mutagenesis in gram-negative bacteria.
Bio/Technology 1: 784–791.
37. Struve C, Krogfelt KA (2003) Role of capsule in Klebsiella pneumoniae
virulence: lack of correlation between in vitro and in vivo studies. FEMS
microbiology letters 218: 149–154.
38. Lawrenz MB, Fodah RA, Gutierrez M, Warawa J (2014) Intubation-mediated
intratracheal (IMIT) instillation: A non-invasive, lung-specific delivery system
JoVE in press.
39. Hsieh PF, Lin TL, Yang FL, Wu MC, Pan YJ, et al. (2012) Lipopolysaccharide
O1 antigen contributes to the virulence in Klebsiella pneumoniae causing
pyogenic liver abscess. PLoS ONE 7: e33155.
40. Liao CH, Huang YT, Lai CC, Chang CY, Chu FY, et al. (2011) Klebsiella
pneumoniae bacteremia and capsular serotypes, Taiwan. Emerging infectious
diseases 17: 1113–1115.
41. Pan YJ, Fang HC, Yang HC, Lin TL, Hsieh PF, et al. (2008) Capsular
polysaccharide synthesis regions in Klebsiella pneumoniae serotype K57 and a
new capsular serotype. J Clin Microbiol 46: 2231–2240.
42. Srinivasan VB, Vaidyanathan V, Mondal A, Rajamohan G (2012) Role of the
two component signal transduction system CpxAR in conferring cefepime and
chloramphenicol resistance in Klebsiella pneumoniae NTUH-K2044. PLoS
ONE 7: e33777.
43. Keynan Y, Rubinstein E (2007) The changing face of Klebsiella pneumoniae
infections in the community. Int J Antimicrob Agents 30: 385–389.
44. Bachman MA, Oyler JE, Burns SH, Caza M, Lepine F, et al. (2011) Klebsiella
pneumoniae yersiniabactin promotes respiratory tract infection through evasion
of lipocalin 2. Infection and immunity 79: 3309–3316.
45. Brisse S, Fevre C, Passet V, Issenhuth-Jeanjean S, Tournebize R, et al. (2009)
Virulent clones of Klebsiella pneumoniae: identification and evolutionary
scenario based on genomic and phenotypic characterization. PLoS One 4:
e4982.
46. Fouts DE, Tyler HL, DeBoy RT, Daugherty S, Ren Q, et al. (2008) Complete
genome sequence of the N2-fixing broad host range endophyte Klebsiella
pneumoniae 342 and virulence predictions verified in mice. PLoS Genet 4:
e1000141.
47. Fumagalli O, Tall BD, Schipper C, Oelschlaeger TA (1997) N-glycosylated
proteins are involved in efficient internalization of Klebsiella pneumoniae by
cultured human epithelial cells. Infection and immunity 65: 4445–4451.
48. Oelschlaeger TA, Tall BD (1997) Invasion of cultured human epithelial cells by
Klebsiella pneumoniae isolated from the urinary tract. Infection and immunity
65: 2950–2958.
49. Lau HY, Clegg S, Moore TA (2007) Identification of Klebsiella pneumoniae
genes uniquely expressed in a strain virulent using a murine model of bacterial
pneumonia. Microb Pathog 42: 148–155.
50. Sahly H, Podschun R, Oelschlaeger TA, Greiwe M, Parolis H, et al. (2000)
Capsule impedes adhesion to and invasion of epithelial cells by Klebsiella
pneumoniae. Infection and immunity 68: 6744–6749.
51. Kabha K, Nissimov L, Athamna A, Keisari Y, Parolis H, et al. (1995)
Relationships among capsular structure, phagocytosis, and mouse virulence in
Klebsiella pneumoniae. Infection and immunity 63: 847–852.
52. Pan PC, Chen HW, Wu PK, Wu YY, Lin CH, et al. (2011) Mutation in fucose
synthesis gene of Klebsiella pneumoniae affects capsule composition and
virulence in mice. Experimental biology and medicine 236: 219–226.
53. Pan YJ, Lin TL, Hsu CR, Wang JT (2011) Use of a Dictyostelium model for
isolation of genetic loci associated with phagocytosis and virulence in Klebsiella
pneumoniae. Infection and immunity 79: 997–1006.
54. Yeh KM, Kurup A, Siu LK, Koh YL, Fung CP, et al. (2007) Capsular serotype
K1 or K2, rather than magA and rmpA, is a major virulence determinant for
Klebsiella pneumoniae liver abscess in Singapore and Taiwan. Journal of clinical
microbiology 45: 466–471.
55. Lin JC, Chang FY, Fung CP, Xu JZ, Cheng HP, et al. (2004) High prevalence of
phagocytic-resistant capsular serotypes of Klebsiella pneumoniae in liver abscess.
Microbes and infection/Institut Pasteur 6: 1191–1198.
56. Warawa JM, Long D, Rosenke R, Gardner D, Gherardini FC (2011)
Bioluminescent diagnostic imaging to characterize altered respiratory tract
colonization by the Burkholderia pseudomallei capsule mutant. Frontiers in
microbiology 2: 133.
57. Yadav V, Sharma S, Harjai K, Mohan H, Chhibber S (2003) Induction &
resolution of lobar pneumonia following intranasal instillation with Klebsiella
pneumoniae in mice. The Indian journal of medical research 118: 47–52.
58. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, et al. (2001)
Requirement of interleukin 17 receptor signaling for lung CXC chemokine
and granulocyte colony-stimulating factor expression, neutrophil recruitment,
and host defense. The Journal of experimental medicine 194: 519–527.
K. pneumoniae Respiratory Disease
PLOS ONE | www.plosone.org 11 September 2014 | Volume 9 | Issue 9 | e107394
